GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Novolog Pharm Up 1966 NVLG.TA · ILA

Health Care · Tel Aviv · 🇮🇱 Israel

Compare

76.60

-2.17%

Close of 9 Nov 2026, in ILA

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in ILS, from our data supplier.

FY2025

Revenue

ILS 1.81bn

FY2016FY2025

Net income

ILS 4.1m

FY2016FY2025

Free cash flow

−ILS 34.2m

FY2016FY2025

Shareholders' equity

ILS 356.9m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueILS 1.81bnILS 2.02bnILS 1.64bnILS 1.51bnILS 1.26bnILS 1.13bnILS 1.00bnILS 911.2mILS 839.8mILS 739.2m
Gross profitILS 124.1mILS 180.8mILS 173.8mILS 176.1mILS 149.0mILS 129.3mILS 98.6mILS 84.3mILS 70.5mILS 72.3m
Research and development———ILS 536,000——————
Operating incomeILS 26.4mILS 62.3mILS 2.7mILS 78.8mILS 69.9mILS 61.1mILS 33.1mILS 31.4mILS 30.7mILS 39.7m
Net incomeILS 4.1mILS 39.5m−ILS 42.0mILS 47.5mILS 42.3mILS 40.1mILS 10.1mILS 21.9mILS 22.5mILS 29.1m
Diluted earnings per share0.010.08-0.080.090.080.090.020.060.060.08

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsILS 2.15bnILS 3.04bnILS 2.79bnILS 2.43bnILS 2.29bnILS 2.19bnILS 2.15bnILS 1.73bnILS 1.81bnILS 1.52bn
Cash and short-term investmentsILS 121.8mILS 247.6mILS 232.9mILS 172.8mILS 238.7mILS 176.4mILS 185.1mILS 108.0mILS 142.4mILS 138.9m
Total liabilitiesILS 1.78bnILS 2.65bnILS 2.39bnILS 1.97bnILS 1.86bnILS 1.89bnILS 1.89bnILS 1.63bnILS 1.72bnILS 1.45bn
DebtILS 183.2mILS 198.5mILS 215.2mILS 212.8mILS 166.8mILS 154.2mILS 158.0mILS 622,000ILS 7.5m—
Shareholders' equityILS 356.9mILS 368.4mILS 371.1mILS 436.0mILS 424.4mILS 294.7mILS 263.8mILS 101.6mILS 85.7mILS 70.7m
Shares outstanding511m511m511m515m505m464m463m350m350m350m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−ILS 16.5mILS 158.5mILS 200.0mILS 132.6mILS 83.4mILS 58.5mILS 101.5mILS 24.0mILS 86.4mILS 20.3m
Capital spending−ILS 17.7m−ILS 58.7m−ILS 71.0m−ILS 69.5m−ILS 30.6m−ILS 25.6m−ILS 25.0m−ILS 29.3m−ILS 34.9m−ILS 13.3m
Free cash flow−ILS 34.2mILS 99.8mILS 129.1mILS 63.2mILS 52.8mILS 32.9mILS 76.4m−ILS 5.3mILS 51.5mILS 7.0m
Dividends paid−ILS 20.0m−ILS 40.0m−ILS 16.9m−ILS 31.9m−ILS 32.0m−ILS 12.0m−ILS 15.5m−ILS 8.3m−ILS 16.0m−ILS 50.0m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueILS 451.9mILS 505.8mILS 373.3mILS 483.6mILS 441.7mILS 506.9mILS 689.9mILS 465.7m
Gross profitILS 36.3mILS 31.1mILS 33.2mILS 37.1mILS 35.5mILS 31.6mILS 44.6mILS 44.4m
Operating incomeILS 8.5mILS 5.1mILS 5.6mILS 11.7mILS 15.8mILS 3.4mILS 7.7mILS 16.9m
Net incomeILS 559,000ILS 442,000−ILS 5.6mILS 4.0mILS 4.8mILS 1.0mILS 1.2mILS 11.9m
Diluted earnings per share0.000.00-0.010.010.010.000.000.02
Cash from operationsILS 42.0mILS 56.0m−ILS 44.0mILS 15.0mILS 127.0m−ILS 109.0mILS 40.0mILS 43.0m
Capital spending−ILS 8.0m−ILS 4.0m−ILS 7.0m−ILS 21.0m−ILS 11.0m−ILS 20.0m−ILS 16.0m−ILS 16.0m
Free cash flowILS 34.0mILS 52.0m−ILS 51.0m−ILS 6.0mILS 116.0m−ILS 129.0mILS 24.0mILS 27.0m
Total assetsILS 2.71bnILS 2.44bnILS 2.15bnILS 3.06bnILS 3.06bnILS 3.12bnILS 3.04bnILS 3.16bn
Cash and short-term investmentsILS 204.5mILS 163.2mILS 121.8mILS 222.2mILS 218.5mILS 111.2mILS 247.6mILS 239.9m
DebtILS 17.3mILS 21.2mILS 25.2mILS 49.2mILS 25.2mILS 25.1mILS 21.3mILS 26.5m
Shareholders' equityILS 350.9mILS 358.0mILS 356.9mILS 372.0mILS 376.2mILS 370.4mILS 368.4mILS 377.8m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue6.2%9.8%10.2%
Operating income-30.5%-15.4%-3.2%
Net income-55.8%-36.6%-16.6%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin8.0%9.4%10.0%9.8%
Operating margin2.3%2.4%3.2%3.5%
Net margin1.1%0.7%1.4%1.8%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings155.923.4-17.630.135.535.577.217.925.5
Price to sales0.40.50.50.91.21.30.80.40.7

Dividends and splits

Per share, in the currency the company pays

Paid for 9 years. Last went ex-dividend on 1 Dec 2025.

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Paid in the year0.0390.0780.0330.0630.0630.0260.0430.024

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.